Melbourne event April 3rd, page-23

Nothing further Supertramp, but I guess you would expect me to say that. My own independent opinion based on my understanding of the company science, its board, external occurrences and a whole bunch of other factors I would not be surprised to see an initial partnership deal being made with someone like Genentech/Roche sooner rather than later. A deal like this would move IMU to something very north of .10 cents IMO. A deal will happen, it is just a matter of whom and when but I don’t think it is far away and there could be multiple parties in contention. Sit back and wait.